Ben Goldacre

Showing 5 posts of 5 posts found.

Scales of justice

Judge rules pharma has ‘ethical’ transparency obligation – reaction

July 29, 2015
Research and Development Ben Goldacre, Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, sense about science, transparency

Both sides of a bitterly contested legal battle over a major part of the industry’s transparency drive have reacted to …

World Health Organisation calls for full trial transparency

April 14, 2015
Research and Development, Sales and Marketing Ben Goldacre, EU, WHO, World Health Organisation, alltrials, clinical trials, sense about science, transparency

The World Health Organization has thrown its weight behind clinical trial transparency in a new statement on its position. WHO …

EMA image

Mixed response to EMA data transparency plans

October 3, 2014
Medical Communications, Research and Development, Sales and Marketing AbbVie, BMJ, Ben Goldacre, EMA, alltrials, transparency

The European Medicines Agency has passed new rules that will mandate pharma to release more of its clinical trial data …

Dr Ben Goldacre

Dr Ben Goldacre: “This is a very broken system”

October 19, 2010
Medical Communications, Research and Development, Sales and Marketing Bad Science, Ben Goldacre, industry reputation, trial data

The pharma industry has its fair share of critics, but unfortunately for everybody, many are easy to dismiss – shrill, …

Researchers unearth Pfizer’s buried data

October 14, 2010
Research and Development Ben Goldacre, Pfizer, publication, reboxetine, trial data

Researchers from Germany’s cost-effectiveness body IQWiG have unearthed a mountain of unpublished data from trials of Pfizer’s reboxetine that show …

Latest content